Prestige Consumer Healthcare (PBH) Interest Coverage Ratio Growth (3y) (2013 - 2025)
Prestige Consumer Healthcare (PBH) Interest Coverage Ratio Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -3.69% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 75.30% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -72.71% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -2.64% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 37.62% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.36 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.31% |
| Sep 30, 2025 | -19.64% |
| Jun 30, 2025 | -16.64% |
| Mar 31, 2025 | 79.73% |
| Dec 31, 2024 | 17.66% |
| Sep 30, 2024 | 12.09% |
| Jun 30, 2024 | -1.78% |
| Mar 31, 2024 | -41.40% |
| Dec 31, 2023 | 7.86% |
| Sep 30, 2023 | 6.50% |
| Jun 30, 2023 | 9.64% |
| Mar 31, 2023 | 108.59% |
| Dec 31, 2022 | 97.03% |
| Sep 30, 2022 | 21.96% |
| Jun 30, 2022 | 102.06% |
| Mar 31, 2022 | -44.21% |
| Dec 31, 2021 | 7.14% |
| Sep 30, 2021 | 13.39% |
| Jun 30, 2021 | 24.34% |
| Mar 31, 2021 | 64.87% |